ArticleCell communication and signaling : CCS2025

Differential regulation of mTORC2 signalling by type I and type II calreticulin (CALR) driver mutations of myeloproliferative neoplasm.

Saadia Naseer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.